Relationship of obesity-related disturbances with LH/FSH ratio among post-menopausal women in the United States

Maturitas

Volumn 71, Issue 1, 2012, Pages 55-61

  Beydoun, Hind A ^a   Beydoun, May A ^b   Wiggins, Natasha ^c   Stadtmauer, Laurel ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c ORISE/NMPHC   (United States)

Author keywords

Chronic inflammation; Follicular stimulating hormone; Insulin resistance; Luteinizing hormone; Obesity

Indexed keywords

C REACTIVE PROTEIN; FOLLITROPIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CHRONIC INFLAMMATION; CLINICAL EVALUATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HUMAN; HYSTERECTOMY; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; MORBIDITY; NUTRITION; OBESITY; OUTCOME ASSESSMENT; OVARY POLYCYSTIC DISEASE; POSTMENOPAUSE; PROTEIN BLOOD LEVEL; PROTEIN HOMEOSTASIS; REGRESSION ANALYSIS; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; UNITED STATES; WAIST CIRCUMFERENCE;

ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CHOLESTEROL, HDL; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; DYSLIPIDEMIAS; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; LUTEINIZING HORMONE; MIDDLE AGED; NUTRITION SURVEYS; OBESITY; POLYCYSTIC OVARY SYNDROME; POSTMENOPAUSE;

EID: 84855419447     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2011.10.010     Document Type: Article

References (29)

1. C. Moran, E. Garcia-Hernandez, E. Barahona, S. Gonzalez, and J.A. Bermudez Relationship between insulin resistance and gonadotropin dissociation in obese and nonobese women with polycystic ovary syndrome Fertil Steril 80 December (6) 2003 1466 1472 (Pubitemid 37532464)
2. M.A. Brown, and R.J. Chang Polycystic ovary syndrome: clinical and imaging features Ultrasound Q 23 December (4) 2007 233 238 (Pubitemid 350307451)
3. D.A. Dumesic, D.H. Abbott, and V. Padmanabhan Polycystic ovary syndrome and its developmental origins Rev Endocr Metab Disord 8 2 2007 Jun 127 141 (Pubitemid 47434646)
4. M.F. Costello, B. Shrestha, J. Eden, N.P. Johnson, and P. Sjoblom Metformin versus oral contraceptive pill in polycystic ovary syndrome: a Cochrane review Hum Reprod 22 May (5) 2007 1200 1209 (Pubitemid 47062785)
5. A. Dunaif Drug insight: insulin-sensitizing drugs in the treatment of polycystic ovary syndrome - a reappraisal Nat Clin Pract Endocrinol Metab 4 May (5) 2008 272 283 (Pubitemid 351571139)
6. E. Deligeoroglou, C. Kouskouti, and P. Christopoulos The role of genes in the polycystic ovary syndrome: predisposition and mechanisms Gynecol Endocrinol 25 September (9) 2009 603 609
7. ACOG Practice Bulletin No. 108: polycystic ovary syndrome Obstet Gynecol 114 October (4) 2009 936 949
8. E. Martinez-Bermejo, M. Luque-Ramirez, and H.F. Escobar-Morreale Obesity and the polycystic ovary syndrome Minerva Endocrinol 32 September (3) 2007 129 140
9. L.J. Moran, R. Pasquali, H.J. Teede, K.M. Hoeger, and R.J. Norman Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society Fertil Steril 92 December (6) 2009 1966 1982
10. J. Vrbikova, and V. Hainer Obesity and polycystic ovary syndrome Obes Facts 2 1 2009 26 35
11. G. Garruti, R. Depalo, and M.G. Vita Adipose tissue, metabolic syndrome and polycystic ovary syndrome: from pathophysiology to treatment Reprod Biomed Online 19 October (4) 2009 552 563
12. M. Magnotti, and W. Futterweit Obesity and the polycystic ovary syndrome Med Clin North Am 91 November (6) 2007 1151 1168 ix-x (Pubitemid 47628858)
13. B. Banaszewska, R.Z. Spaczynski, M. Pelesz, and L. Pawelczyk Incidence of elevated LH/FSH ratio in polycystic ovary syndrome women with normo- and hyperinsulinemia Rocz Akad Med Bialymst 48 2003 131 134
14. A.J. Cussons, B.G. Stuckey, J.P. Walsh, V. Burke, and R.J. Norman Polycystic ovarian syndrome: marked differences between endocrinologists and gynaecologists in diagnosis and management Clin Endocrinol (Oxf) 62 March (3) 2005 289 295 (Pubitemid 40380408)
15. K. Guzelmeric, N. Alkan, M. Pirimoglu, O. Unal, and C. Turan Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome Gynecol Endocrinol 23 September (9) 2007 505 510 (Pubitemid 47628538)
16. H. Kurioka, K. Takahashi, and K. Miyazaki Glucose intolerance in Japanese patients with polycystic ovary syndrome Arch Gynecol Obstet 275 March (3) 2007 169 173 (Pubitemid 46221270)
17. J.W. Lee, J.A. Im, D.C. Lee, H.R. Lee, and J.Y. Shim Retinol-binding protein in nonobese women with polycystic ovary syndrome Clin Endocrinol (Oxf) 68 May (5) 2008 786 790
18. E. Mor, A. Zograbyan, and P. Saadat The insulin resistant subphenotype of polycystic ovary syndrome: clinical parameters and pathogenesis Am J Obstet Gynecol 190 June (6) 2004 1654 1660 (Pubitemid 39006202)
19. R. Yildizhan, M. Kurdoglu, and E. Adali Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome Arch Gynecol Obstet 280 4 2009 Oct 559 563
20. D.A. Lacher, T.D. Thompson, J.P. Hughes, and M. Saraiya Total, free, and percent free prostate-specific antigen levels among U.S. men, 2001-04 Adv Data 4 December (379) 2006 1 12
21. D.A. Joseph, T. Thompson, M. Saraiya, and D.M. Werny Association between glomerular filtration rate, free, total, and percent free prostate-specific antigen Urology 76 Nov (5) 2010 1042 1046
22. A.M. Mondul, E. Selvin, A.M. De Marzo, S.J. Freedland, and E.A. Platz Statin drugs, serum cholesterol, and prostate-specific antigen in the National Health and Nutrition Examination Survey 2001-2004 Cancer Causes Control 21 May (5) 2010 671 678
23. S.M. Grundy, J.I. Cleeman, and S.R. Daniels Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary Cardiol Rev 13 November-December (6) 2005 322 327 (Pubitemid 41579599)
24. A. Katsuki, Y. Sumida, and E.C. Gabazza Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes Diabetes Care 24 2 2001 Feb 362 365 (Pubitemid 32119139)
25. J.B. Henrich, J.P. Hughes, S.C. Kaufman, D.J. Brody, and L.R. Curtin Limitations of follicle-stimulating hormone in assessing menopause status: findings from the National Health and Nutrition Examination Survey (NHANES 1999-2000)* Menopause 13 March-April (2) 2006 171 177
26. Wiacek M, Jegal BS, Hagner W, Hagner-Derengowska M, Zubrzycki IZ. Age- and menopause-related differences in physiological factors of health quality in women aged 35-60. Arch Gerontol Geriatr, May 16.
27. J.A. Marcondes, S.A. Yamashita, G.A. Maciel, E.C. Baracat, and A. Halpern Metformin in normal-weight hirsute women with polycystic ovary syndrome with normal insulin sensitivity Gynecol Endocrinol 23 5 2007 May 273 278 (Pubitemid 46897699)
28. E.H. Yeung, C. Zhang, and S.L. Mumford Longitudinal study of insulin resistance and sex hormones over the menstrual cycle: the BioCycle Study J Clin Endocrinol Metab 95 December (12) 2010 5435 5442
29. A. Lenarcik, B. Bidzinska-Speichert, and U. Tworowska-Bardzinska The role of chronic inflammation and Leu55Met PON1 polymorphism in the pathogenesis of polycystic ovary syndrome Gynecol Endocrinol 26 September (9) 2010 673 683